Full Text
The Full Text of this article is available as a PDF (88.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Edlavitch S. A. Postmarketing surveillance methodologies. Drug Intell Clin Pharm. 1988 Jan;22(1):68–78. doi: 10.1177/106002808802200117. [DOI] [PubMed] [Google Scholar]
- Fletcher A. P. Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J R Soc Med. 1991 Jun;84(6):341–344. doi: 10.1177/014107689108400612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leiper J. M., Lawson D. H. Why do doctors not report adverse drug reactions? Neth J Med. 1985;28(12):546–550. [PubMed] [Google Scholar]
- Shapiro S. The epidemiological evaluation of drugs. Acta Med Scand Suppl. 1984;683:23–27. doi: 10.1111/j.0954-6820.1984.tb08710.x. [DOI] [PubMed] [Google Scholar]
- Strom B. L., Melmon K. L., Miettinen O. S. Postmarketing studies of drug efficacy. Arch Intern Med. 1985 Oct;145(10):1791–1794. [PubMed] [Google Scholar]
- Strom B. L. Overview of different logistical approaches to postmarketing surveillance. J Rheumatol Suppl. 1988 Oct;17:9–13. [PubMed] [Google Scholar]